Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the control of metabolic disorders. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://nanawgib190168.review-blogger.com/60418139/retaglutide-a-promising-glp-1-receptor-agonist